Similar articles

• Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.

  Syngle A, Vohra K, Garg N, Kaur L, Chand P. Syngle A, et al. Int J Rheum Dis. 2012 Feb;15(1):45-55. doi: 10.1111/j.1756-185X.2011.01679.x. Epub 2011 Oct 10. Int J Rheum Dis. 2012. PMID: 22324946
• Determinants of compliance in rheumatoid arthritic patients assessed in their home environment.

  Owen SG, Friesen WT, Roberts MS, Flux W. Owen SG, et al. Br J Rheumatol. 1985 Nov;24(4):313-20. doi: 10.1093/rheumatology/24.4.313. Br J Rheumatol. 1985. PMID: 4063622
• [Pharmacologic therapy of rheumatoid arthritis with delayed-action anti-rheumatic drugs].

  Saal JG. Saal JG. Internist (Berl). 1993 Jan;34(1):9-17. Internist (Berl). 1993. PMID: 8440581 Review. German. No abstract available.
• Update: slow acting anti-rheumatic drugs in rheumatoid arthritis.

  Riedemann JP, Cardiel MH, Tugwell P. Riedemann JP, et al. Compr Ther. 1991 Jun;17(6):61-8. Compr Ther. 1991. PMID: 1934990 Review. No abstract available.
• Polymyalgia rheumatica and elderly onset rheumatoid arthritis.

  Belloli L, Massarotti M, Marasini B. Belloli L, et al. J Clin Rheumatol. 2008 Feb;14(1):59. doi: 10.1097/RHU.0b013e318163c373. J Clin Rheumatol. 2008. PMID: 18431108 No abstract available.